A 66-year-old after infrainguinal revascularization for PAD has no high bleeding risk. Which regimen reduces MACE/MALE?...

Question

A 66-year-old after infrainguinal revascularization for PAD has no high bleeding risk. Which regimen reduces MACE/MALE?

Accepted Answer

Low-dose rivaroxaban 2.5 mg BID plus aspirin 81 mg daily

Answer

Aspirin 81 mg alone

Answer

Full-dose rivaroxaban 20 mg daily alone

Answer

Dual antiplatelet therapy (aspirin + clopidogrel) indefinitely

Answer

No antithrombotic therapy

us-abim MCQ (SBA): Peripheral Artery Disease